Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
CANTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the third quarter ended September 30, 2024.
Read more at globenewswire.com
